Excited to welcome Orchestra Bio and @ashokaraj_ to OpenAI as we broaden our work in AI-assisted drug discovery!
OpenAI acquires Orchestra Bio to expand AI-assisted drug discovery
AIOpenAI says it has acquired Orchestra Bio, a platform that helps biopharma teams coordinate drug development. The company says it will combine Orchestra Bio with Rosalind, its AI models and tools for life sciences research, to streamline operations and help new treatments reach patients sooner.
@markchen90
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/View quoted post on X
This story is featured in top picks: “OpenAI acquires Orchestra Bio to coordinate biopharma drug development”
Source details
Mark Chen · x.comPublished · added here
Original title: Excited to welcome Orchestra Bio and @ashokaraj_ to OpenAI as we broaden our work in AI-assisted drug discovery!